1. Home
  2. PZZA vs COLL Comparison

PZZA vs COLL Comparison

Compare PZZA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

HOLD

Current Price

$20.72

Market Cap

1.2B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$21.84

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZZA
COLL
Founded
1984
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
PZZA
COLL
Price
$20.72
$21.84
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$45.00
$51.40
AVG Volume (30 Days)
1.2M
799.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$2,068,421,000.00
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
N/A
N/A
P/E Ratio
$44.70
N/A
Revenue Growth
14.07
23.62
52 Week Low
$20.53
$22.64
52 Week High
$55.74
$50.79

Technical Indicators

Market Signals
Indicator
PZZA
COLL
Relative Strength Index (RSI) 34.67 22.66
Support Level N/A N/A
Resistance Level $24.25 $35.64
Average True Range (ATR) 0.77 0.97
MACD 0.09 0.00
Stochastic Oscillator 35.44 5.39

Price Performance

Historical Comparison
PZZA
COLL

About PZZA Papa John's International Inc.

Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: